Skip to main content
. 2023 Jul 18;101(3):e238–e252. doi: 10.1212/WNL.0000000000207402

Figure 3. Change From Baseline to End of Treatment (Week 24) in 6-Minute Walk Test: Subgroup Analysis by Genetic Abnormality.

Figure 3

Subgroup analysis by genetic abnormality for change from baseline to end of treatment (week 24) in 6MWT for (A) participants with mtDNA alteration and (B) participants with nDNA alteration.